St Francis Hospice. How common is it? How is it prevented? 10/07/2017. What is delirium? DSM IV criteria. Delirium vs Dementia.

Size: px
Start display at page:

Download "St Francis Hospice. How common is it? How is it prevented? 10/07/2017. What is delirium? DSM IV criteria. Delirium vs Dementia."

Transcription

1 What is delirium? DSM IV criteria St Francis Hospice Dr Hilary Kinsler Disturbance of consciousness reduced clarity of awareness of the environment Change in cognition memory deficit, disorientation, language disturbance, perceptual disturbance occurs that is not better accounted for by a pre-existing, established, or evolving dementia. The disturbance develops over a short period and tends to fluctuate during the course of the day. Evidence from the history, physical examination, or laboratory findings is present that indicates the disturbance is caused by a direct physiologic consequence of a general medical condition, an intoxicating substance, medication use, or more than one cause. Delirium vs Dementia Delirium Dementia Onset Acute Insidious Duration Transient Chronic Course Fluctuating Progressive Attention Reduced Intact initially Consciousness Altered Normal Hallucinations Common Less common Delirium may be superimposed on dementia How common is it? Delirium is common in acute hospitals e.g % In community 22% in general medicine in patients 28% acute orthopaedics 40% Post op 50% Geriatric medicine in patients 80% medical ICU 88% palliative care How is it prevented? The environment: Hearing aids Spectacles Orientation aids Lighting Encourage food and fluid intake Encourage mobility Maintain sleep pattern Involve relatives and carers Avoid: Constipation Catheters Restraint Sedation Bed or Ward moves Arguing with the patient Anticholinergics 1

2 Anticholinergic drugs. Full List of Anticholinergic medication Type of drug Antihistamine Antispasmodic Tricyclic antidepressant Benzodiazepine Analgesic Antiarrhythmic Diuretic Antiparkinsonian Bladder stabiliser Brochodilator Example Hydroxyzine, diphenhydramine Alverine, hyoscyamine Amitriptyline Lorazepam Codeine Digoxin Furosemide Orphenadrine, Procyclidine, benzatropine (more often used in US than UK) Oxybutynin Theophylline Aging brain Care Anticholinergic Burden Scale Evidence Base for Haloperidol in Delirium Author Type Year Outcome Page Boogaard Kalisvaart Kaneko Randomised double Blind ICU 141 patients Before after evaluation ICU RDB prophylactic HPL 1.5mg before hip surgery Randomised Comparative 78 patients 5mg 2013 Negative 2013 Probably +ve 2005 Incidence -ve Severity -+ve Duration +ve 1999 Positive Wang RDB ICU 2012 Positive Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care A Randomized Clinical Trial Meera R. Agar, PhD Jan 2017 Question What are the benefits of risperidone or haloperidol in reducing distressing symptoms of delirium in patients receiving palliative care? Findings In this randomized clinical trial of 247 participants receiving palliative care, distressing behavioral, communication, and perceptual symptoms of delirium were significantly greater in those treated with antipsychotics (risperidone or haloperidol) than in those receiving placebo. Meaning Antipsychotic drugs are not useful to reduce symptoms of delirium associated with distress in patients receiving palliative care. Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials Taro Kishi Sept 2015 Our results suggested that second generation Antipsychotics have a benefit for the treatment of delirium with regard to efficacy and safety compared with haloperidol. However, further study using larger samples is required. If medication is really, really needed Regular risperidone (liquid) up to 0.5mg nocte and 0.5mg PRN (0.25mg if very frail, higher does if less frail) If refuse oral and has to be IM lorazapam 1mg (or haloperidol 1mg) Benzodiazepines make delirium worse. Mirtazapine 15mg nocte can help, comes as orodispersible. More helpful in hyperactive delirium. 2

3 Antipsychotics When are antipsychotic Medications Used? Not just for psychosis! Depression, anxiety, bipolar affective disorder, behavioural problems in dementia, eating disorders, insomnia etc etc. Reduction of antipsychotics in psychotic illnesses Must be done gradually because of risk of relapse and risk of tardive dyskinesia Procyclidine makes tardive dyskinesia worse and increases risk of delirium. Tardive Dyskinesia Abnormal movements which develop either when people are on antipsychotics or a few weeks after they are stopped or dose reduced. Treatment is very difficult. Procyclidine makes it worse but helps parkinsonian side effects of antipsychotics. Potent anticholinergic. Withdrawal symptoms of antipsychotics Agitation Insomnia Rebound psychosis Tardive dyskinesia Anticholinergic rebound: nausea, malaise, diaphoresis, vomiting, and/or insomnia Dementia Medications 3

4 Percentage of patients showing improvement at week 24/28 (LOCF) LS mean change from baseline item score at Week 24 (LOCF) How are they taken? Tablet Capsule Orodispersible tablet Donepezil Galantamine * * Oral solution Transdermal patch Rivastigmine * * Memantine *Twice daily dosing required; all other preparations are administered once daily Donepezil and reduced worsening Pooled data from 3 large trials of donepezil in Alzheimer s disease Definition of clinical worsening incorporated: Cognition Global outcome Function Patients on placebo more likely to show clinical worsening than patients on donepezil NPI 12-item Total: Moderate to Severe AD NPI Individual Item Analysis Donepezil Placebo P = P = P = Clinical improvement Clinical decline How safe are cholinesterase inhibitors? Most common side effects Nausea and vomiting & diarrhoea Cramps Abdominal pain & anorexia Vivid dreams Slow Heart rate Peptic ulcer and gastric bleeding urinary retention and frequency Stopping can be done without reducing dose but risk that cognition crashes. Gauthier S et al. Int J Psychogeriatr. 2002;14: NPI domains: improvement in baseline symptoms Pooled data from six studies (MMSE <20), % of patients showing improvement, NPI single items (LOCF) * Delusions Hallucinations Agitation/aggression Depression/dysphoria Anxiety Elation/euphoria Apathy/indifference Memantine * Disinhibition Irritability/lability Aberrant motor behaviour Placebo Night-time behaviour Appetite/eating change *p<0.05 Gauthier et al. Int J Geriatr Psych 2007 Gauthier et al. Int J Geriatr Psych 2008;23: * * How safe is memantine? No absolute contra-indications BNF advises caution in presence of seizures However no real data one way or the other May need reduced dose in CKD Can be discontinued without reduction but collateral always a good idea. Generally well tolerated. The most common listed side effects are: Constipation Dizziness Headache Hypertension Somnolence 4

5 What I do No point in discontinuing safe medication which reduces agitation unless you have too. Reduce dose in renal failure & stop if severe. Sometimes stopped if seizures but can get seizures in dementia anyway so need to check response. Can be stopped gradually or without titrating but if it has been helping behaviour it can be a disaster to stop suddenly so best to reduce slowly. Response to memantine is very variable so check initial response. In LBD or Dementia in PD. Discontinuing rivastigmine in PD or LBD can cause severe and distressing hallucinations even in someone with very poor cognition. Major Depression Is Associated with Chronic Medical Illness % 25% Antidepressants Prevalence of Major Depression (%) % 4% 5% 10% 6% 14% 0 Community Primary Care Clinic Medical Inpatient Setting Katon W, Schulberg H. Gen Hosp Psychiatry. 1992;14: Rosen J, Mulsant BH, Pollock BG. Nursing Home Med. 1997;5: Nursing Home Prevalence of Depression in Palliative Care Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst. 2004;32: % Antidepressants for the treatment of depression in palliative care: systematic review and metaanalysis Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ Antidepressants for Depression Choice History Risks Biological Symptoms Triad of Early morning wakening, Diurnal mood variation & anhedonia 5

6 Type SSRI Selective serotonin reuptake inhibitor SNRI Selective noradrenaline reuptake inhibitors NaSSA - Noradrenergic and specific serotonergic antidepressants SARI Serotonin antagonist and reuptake inhibitor TCA tricyclic antidepressants Examples Citalopram Escitalopram Paroxetine Fluoxetine Sertraline Fluvoxamine Duloxetine Venlafaxine Desvenlafaxine Mirtazepine Trazodone Amitriptyline Dosulepin Doxepin Imipramine Mirtazapine Helps sleep and increases appetite Not anticholinergic Well tolerated Over sedation and postural hypotension are main side effects Comes as orodispersible and as a liquid Withdrawal symptoms 53% have withdrawal symptoms. anxiety (70%) dizziness (61%) vivid dreams (51%) electric shocks / head zaps (48%) stomach upsets (33%) flu like symptoms (32%) depression (7%) headaches (3%) suicidal thoughts (2%) insomnia (2%). Do antidepressants work in dementia? Depression affects up to 43% of patients with dementia Likely to be offered antidepressant medication Evidence that antidepressants work for depression in dementia is patchy HTA-SADD study (Banerjee et al, 2011 Lancet) No consistent benefits on symptoms of depression - Sertraline no effect - Mirtazapine reduced carer burden Lack of efficacy of antidepressants suggests different pathogenic mechanisms for depression in AD Anticholinergic Medications Treating bladder symptoms in dementia 1st line review bladder anticholinergic, use non-drug measures 2nd line: trospium (non-selective but poor penetration through BBB, P-gp substrate and no CYP450 function, low risk of interactions) darifenacin (selective and P-gp substrate). 3rd line: solifenacin (somewhat selective but readily penetrates BBB, not P-gp substrate and has potential to cause cognitive impairment). Data for fesoterodine is still lacking but it is non-selective, has high central anticholinergic activity but theoretically has low ability to cross BBB. Or use Mirabegron 6

7 Antiemetics For people with dementia cyclizine,metoclopramide, and prochlorperazine should not be first line antiemetics. Hyoscine hydrobromide (Kwells) should be avoided Domperidone is a good first line choice and 5- HT3 antagonists are also safe to use Benzodiazepines What I do with benzos Extremely, extremely cautious if on long term treatment. Incredibly slow reductions if really essential. Can get psychotic symptoms and symptoms suggestive of delirium. I have had some disasters! Withdrawal symptoms Anxiety and Perceptual distortions Anxiety, irritability, excitability, panic attacks Sleep disturbance Visual disturbance, sweating Altered mood, paranoid thoughts Hypersensitivity (light, sound, touch, taste, smell) Abnormal body sensations Depersonalisation, derealisation Depression Physical symptoms Tremor, muscle spasms, hyperventilation Anorexia, weight loss Major events Generalised seizures Precipitation of delirium or psychotic symptoms Lithium Continue as long as possible! Safer opiates in dementia Buprenorphine- fewer side effects and patch makes administration easier Oxycodone- short half-life, few drug-drug interactions, predictable dose-response 7

8 Antihistamines Antiepileptics Avoid first generation drugs - chlorpheniramine, clemastine, promethazine, cyclizine, cyproheptadine, hydroxyzine Second generation drugs are safe- loratadine, fexofenadine, cetirizine BNF defines which are sedative and nonsedative Topiramate and Levetiracetam Agitation, anxiety, nervousness, depression, emotional lability, irritability, hostility, aggressive behaviour and psychosis. Steroids Prednisolone. Poor sleep, increased appetite, elated mood, irritability, visual hallucinations, psychosis. Depression, muscle pain, lethargy on withdrawal. 8

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on

More information

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics Cognitive enhancers PINCH ME Anticholinergic burden BPSD Agitation, Aggression and antipsychotics 2 types Cholinesterase inhibitors licensed for mild to moderate AD Donepezil Galantamine Rivastigmine also

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

Primary Care Prescribing Protocol to Support the Diagnosis and Management of People with Dementia

Primary Care Prescribing Protocol to Support the Diagnosis and Management of People with Dementia Primary Care Prescribing Protocol to Support the Diagnosis and Management of People with Dementia This prescribing guideline provides the necessary information and guidance to support clinicians in the

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Antidepressant Pharmacology An Overview

Antidepressant Pharmacology An Overview Figure 1. Antidepressant Pharmacology An Overview Source: NEJM 2005;353:1819-34 Figure 2. 1 Figure 3: Antidepressant Pharmacology pictures: Weak inhibition Bupropion NOTE: CYP enzymes noted are those inhibited

More information

A Basic Approach to Mood and Anxiety Disorders in the Elderly

A Basic Approach to Mood and Anxiety Disorders in the Elderly A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict

More information

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE? USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE? Mugdha Thakur, MD Associate Professor of Psychiatry and Behavioral Sciences Duke University

More information

ANTI-DEPRESSANT MEDICATIONS

ANTI-DEPRESSANT MEDICATIONS ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change

More information

Delirium. Assessment and Management

Delirium. Assessment and Management Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about

More information

Essential Shared Care Agreement Drugs for Dementia

Essential Shared Care Agreement Drugs for Dementia E098 Essential Shared Care Agreement Drugs for Dementia Please complete the following details: Patient s name, address, date of birth Consultant s contact details (p.3) And send One copy to: 1. the patient

More information

Depression in Late Life

Depression in Late Life Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression

More information

Anxiety Disorders.

Anxiety Disorders. Anxiety Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

Antidepressant Treatment of Depression

Antidepressant Treatment of Depression Antidepressant Treatment of Depression PLEASE REFER TO INTEGRATED CARE PATHWAY FOR INFORMATION RELATING TO THE OVERALL MANAGEMENT OF DEPRESSION SSRI s are first choice agents because they are as effective

More information

Volume 4; Number 5 May 2010

Volume 4; Number 5 May 2010 Volume 4; Number 5 May 2010 CLINICAL GUIDELINES FOR ANTIDEPRESSANT USE IN PRIMARY AND SECONDARY CARE Lincolnshire Partnership Foundation Trust in conjunction with Lincolnshire PACEF have recently updated

More information

Essential Shared Care Agreement Drugs for Dementia

Essential Shared Care Agreement Drugs for Dementia Ref No. E052 Please complete the following details: Patient s name, address, date of birth Consultant s contact details (p.3) And send One copy to: 1. the patient s GP 2. put one copy in care plan 3. give

More information

Mood Disorders.

Mood Disorders. Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Katee Kindler, PharmD, BCACP

Katee Kindler, PharmD, BCACP Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,

More information

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital with thanks to Jonathan Cavan for his input Aims Define BPSD and common symptoms

More information

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen Delirium Dr. Lesley Wiesenfeld Deputy Psychiatrist in Chief, Mount Sinai Hospital Dr. Carole Cohen Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre Case Study Mrs B

More information

This initial discovery led to the creation of two classes of first generation antidepressants:

This initial discovery led to the creation of two classes of first generation antidepressants: Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out

More information

GREATER MANCHESTER INTERFACE PRESCRIBING GROUP

GREATER MANCHESTER INTERFACE PRESCRIBING GROUP GREATER MANCHESTER INTERFACE PRESCRIBING GROUP On behalf of the GREATER MANCHESTER MEDICINES MANAGEMENT GROUP SHARED CARE GUIDELINE FOR THE PRESCRIBING OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)

More information

Antidepressant Selection in Primary Care

Antidepressant Selection in Primary Care Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.

More information

BIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs

BIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs BIOLOGICAL TREATMENT IN PSYCHIATRY PTE ÁOK Dept.of Psychiatry Pécs 1 SGA effects pharmacokinetic effect chemical strucrure Receptor block D2 5-HT2 α1 H-1 M Selectíve DA (D2D3) antagonists Benzamids Amisulpiride

More information

Presenter. Dr. Ronald Lucchino

Presenter. Dr. Ronald Lucchino Adverse Drug Reactions in Adults with Down Syndrome Presenter Dr. Ronald Lucchino rvluc@comcast.net PURPOSE To increase staff awareness that older adults with DD may have higher levels of medication in

More information

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable

More information

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future Daniel S. Sitar Professor Emeritus University of Manitoba Email: Daniel.Sitar@umanitoba.ca March 6, 2018 INTRODUCTION EPIDEMIOLOGY

More information

Depression: selective serotonin reuptake inhibitors

Depression: selective serotonin reuptake inhibitors Depression: selective serotonin reuptake inhibitors Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for the majority of patients with depression. citalopram and fluoxetine

More information

Effective Shared Care Agreement (ESCA) for drugs used in dementia- Donepezil, Galantamine, Rivastigmine and Memantine

Effective Shared Care Agreement (ESCA) for drugs used in dementia- Donepezil, Galantamine, Rivastigmine and Memantine Effective Shared Care Agreement (ESCA) for drugs used in dementia- Donepezil, Galantamine, Rivastigmine and Memantine for the treatment of dementia AREAS OF RESPONSIBILITY FOR THE SHARING OF CARE This

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Mental illness A Broad Overview. Dr H Pathmanandam March 2017

Mental illness A Broad Overview. Dr H Pathmanandam March 2017 Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate

More information

DEMENTIA AND MEDICATION

DEMENTIA AND MEDICATION DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Psychotropic Strategies Handout Package

Psychotropic Strategies Handout Package Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles

More information

Diagnosis and Treatment of Alzhiemer s Disease

Diagnosis and Treatment of Alzhiemer s Disease Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised

More information

Anti-Depressant Medications

Anti-Depressant Medications Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change

More information

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018 From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018 Overview What is dementia? Common causes Normal cognitive decline Abnormal decline and mild cognitive impairment How do we manage dementia Can

More information

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D. Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS

More information

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define

More information

Medical and Behavioral Health: A Delicate Balance

Medical and Behavioral Health: A Delicate Balance Medical and Behavioral Health: A Delicate Balance Mae Centeno DNP, RN, CCRN,CCNS,ACNS-BC Corporate Director Chronic Care Continuum Jeff Place MSN,MBA,RN Director BUMC Nursing Service Support 1 Background

More information

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT

More information

Alison Charleston 1 st September 2016

Alison Charleston 1 st September 2016 Alison Charleston 1 st September 2016 Clinical features of Parkinson s disease Differential diagnosis Management of the motor features Non-motor and neuropsychiatric aspects 100-200 per 100,000 prevalence

More information

Safe Prescribing in Dementia

Safe Prescribing in Dementia Safe Prescribing in Dementia Dr Daniel Harwood Consultant Psychiatrist and Clinical Director, London Strategic Clinical Network Gurdeep Kaur Major Rapid Access Team Senior Pharmacist, Camden CNWL NHS Trust

More information

Shared Care Agreement for Donepezil, Galantamine, Rivastigmine and Memantine

Shared Care Agreement for Donepezil, Galantamine, Rivastigmine and Memantine Clinical SECONDARY CARE SECTION TO BE COMPLETED BY INITIATING DOCTOR Patient s Name: Date of Birth: NHS Number: Date Treatment Started: Name of drug: (Add Date) One copy of information leaflet given to

More information

Alzheimer s Disease. Pathophysiology: Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior,

Alzheimer s Disease. Pathophysiology: Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior, 2 Alzheimer s Disease Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior, and functional status with no known cause or cure. Patients eventually lose cognitive, analytical,

More information

The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability

The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability Danielle Adams Principal Clinical Pharmacist Pharmacy and Medicines Optimisation Team HPFT July 2017 1

More information

Presentation is Being Recorded

Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD Psychopharmacology at the End of Life Nicole Thurston, MD Psychiatrist Mountain States Tumor Institute Objectives Describe 2 common psychiatric symptoms that can present at or near end of life. Review

More information

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Delirium. Approach. Symptom Update Masterclass:

Delirium. Approach. Symptom Update Masterclass: Symptom Update Masterclass: Delirium Jason Boland Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine Wolfson Centre for Palliative Care Research Hull York Medical School University

More information

Quick Guide to Common Antidepressants-Adults

Quick Guide to Common Antidepressants-Adults Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa

More information

Management of Delirium in Hospice Patients

Management of Delirium in Hospice Patients Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying

More information

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,

More information

Antidepressant Selection in Primary Care

Antidepressant Selection in Primary Care Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA Unmet needs What might be your behavioural response to this experience? Content Definition What are BPSD? Prevalence How common are they? Aetiological

More information

Use of Psychotropic Medications in Older Adults with Dementia!

Use of Psychotropic Medications in Older Adults with Dementia! Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with

More information

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry Cognitive disorders Dr S. Mashaphu Department of Psychiatry Delirium Syndrome characterised by: Disturbance of consciousness Impaired attention Change in cognition Develops over hours-days Fluctuates during

More information

Treatments for migraine

Treatments for migraine Treatments for migraine Information for patients and carers Department of Neurology Aberdeen Royal Infirmary Contents Page About this leaflet Abortive medication for migraine Painkillers Antisickness medication

More information

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please

More information

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.)

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.) Drug Management of Parkinsonism By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.) Drug management of Parkinsonism Levodopa Ergot derivatives noamine Oxidaes Inhibitors Catechol-Omethyl

More information

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources Drugs and Dementia in the Hospice Patient Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources 1 Drug Therapy: Targeted at Symptoms Cognitive: Impaired abstract thinking Impaired

More information

Pharmacotherapy of depression

Pharmacotherapy of depression Pharmacotherapy of depression Stuff you already know Stuff you probably know Stuff you possibly don t know Stuff you thought you knew but are mistaken about How long does it take for antidepressants

More information

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS A REALITY CHECK reality check Noun informal an occasion on which one is reminded of the state of things in the real world. ROBERT LACOSTE, MD MEDICAL DIRECTOR,

More information

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence Causes of Transient Geriatrics: Urinary, Dementia, and Delirium Carla Zeilmann, PharmD, BCPS St. Louis College of Pharmacy Therapeutics 3 Fall 2003 D delirium I infection A atrophic urethritis and vaginitis

More information

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions

More information

South London and the Maudsley NHS Foundation Trust Medicines Formulary

South London and the Maudsley NHS Foundation Trust Medicines Formulary South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1

More information

Any interventions, where RCTs in PD are not available, are not included in the tables.

Any interventions, where RCTs in PD are not available, are not included in the tables. Tables Interventions where new studies have been published are indicated in bold italics. Changes in conclusions are indicated in italics and are highlighted in yellow. Any interventions, where RCTs in

More information

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty

More information

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual

More information

Behavioral and Psychological Symptoms of dementia (BPSD)

Behavioral and Psychological Symptoms of dementia (BPSD) Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management

More information

Major Depression and Anxiety in Adolescents and Adults

Major Depression and Anxiety in Adolescents and Adults Major Depression and Anxiety in Adolescents and Adults Miggie Greenberg, M.D. Associate Professor of Psychiatry St. Louis University School of Medicine greenbml@slu.edu *NO DISCLOSURES* OBJECTIVES * Recognize

More information

Addressing Difficult Behaviors in Dementia

Addressing Difficult Behaviors in Dementia Addressing Difficult Behaviors in Dementia GEORGE SCHOEPHOERSTER, MD GERIATRICIAN GENEVIVE/CENTRACARE CLINIC Objectives By the end of the session, you will be able to: 1) Explain the role of pain management

More information

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned

More information

Anticholinergic (Antimuscarinic) Guidelines. Treatment of Antipsychotic Induced Extra Pyramidal Side Effects (EPSE)

Anticholinergic (Antimuscarinic) Guidelines. Treatment of Antipsychotic Induced Extra Pyramidal Side Effects (EPSE) Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire West Primary Care Alliance Anticholinergic (Antimuscarinic)

More information

Psycholeptics, anti-depressants, antiepileptic, anti-ra and anti-spastic medications available at Zithulele hospital

Psycholeptics, anti-depressants, antiepileptic, anti-ra and anti-spastic medications available at Zithulele hospital Psycholeptics, anti-depressants, antiepileptic, anti-ra and anti-spastic medications available at Zithulele hospital Note that with the exception of NSAIDs, none of the following medications are available

More information

Management of Behavioral Problems in Dementia

Management of Behavioral Problems in Dementia Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of

More information

Antipsychotics for Dementia Under Control or Over-Prescribed?

Antipsychotics for Dementia Under Control or Over-Prescribed? Antipsychotics for Dementia Under Control or Over-Prescribed? Nathaniel Hedrick, PharmD ProCare HospiceCare, Manager of Clinical Services Learning Objectives Summarize the disease progression and most

More information

Depression & Anxiety in Adolescents

Depression & Anxiety in Adolescents Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with

More information

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant. 1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number

More information

Treatment of Alzheimer s disease

Treatment of Alzheimer s disease NORTH AND EAST DEVON HEALTHCARE COMMUNITY SHARED CARE PRESCRIBING GUIDELINE http://www.devonpct.nhs.uk/treatments/ne_devon_shared_care_guidelines.aspx#a Treatment of Alzheimer s disease Acetylcholinesterase

More information

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017

More information